Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16219141rdf:typepubmed:Citationlld:pubmed
pubmed-article:16219141lifeskim:mentionsumls-concept:C0149543lld:lifeskim
pubmed-article:16219141lifeskim:mentionsumls-concept:C0178602lld:lifeskim
pubmed-article:16219141lifeskim:mentionsumls-concept:C2931822lld:lifeskim
pubmed-article:16219141lifeskim:mentionsumls-concept:C0034897lld:lifeskim
pubmed-article:16219141lifeskim:mentionsumls-concept:C1306673lld:lifeskim
pubmed-article:16219141lifeskim:mentionsumls-concept:C1511253lld:lifeskim
pubmed-article:16219141pubmed:issue10lld:pubmed
pubmed-article:16219141pubmed:dateCreated2005-10-12lld:pubmed
pubmed-article:16219141pubmed:abstractTextThe recurrence rate in skull base is high for nasopharyngeal carcinoma (NPC) patients with cavernous sinus or/and sphenoid sinus involvement. This study was conducted to explore the impact of dose boost in skull base on the recurrence in skull base and survival of NPC patients with cavernous sinus or/and sphenoid sinus involvement.lld:pubmed
pubmed-article:16219141pubmed:languagechilld:pubmed
pubmed-article:16219141pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16219141pubmed:citationSubsetIMlld:pubmed
pubmed-article:16219141pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16219141pubmed:statusMEDLINElld:pubmed
pubmed-article:16219141pubmed:monthOctlld:pubmed
pubmed-article:16219141pubmed:issn1000-467Xlld:pubmed
pubmed-article:16219141pubmed:authorpubmed-author:YinLiLlld:pubmed
pubmed-article:16219141pubmed:authorpubmed-author:HuangPei-YuPYlld:pubmed
pubmed-article:16219141pubmed:authorpubmed-author:CaoKa-JiaKJlld:pubmed
pubmed-article:16219141pubmed:authorpubmed-author:XieGuo-FengGFlld:pubmed
pubmed-article:16219141pubmed:issnTypePrintlld:pubmed
pubmed-article:16219141pubmed:volume24lld:pubmed
pubmed-article:16219141pubmed:ownerNLMlld:pubmed
pubmed-article:16219141pubmed:authorsCompleteYlld:pubmed
pubmed-article:16219141pubmed:pagination1246-8lld:pubmed
pubmed-article:16219141pubmed:meshHeadingpubmed-meshheading:16219141...lld:pubmed
pubmed-article:16219141pubmed:meshHeadingpubmed-meshheading:16219141...lld:pubmed
pubmed-article:16219141pubmed:meshHeadingpubmed-meshheading:16219141...lld:pubmed
pubmed-article:16219141pubmed:meshHeadingpubmed-meshheading:16219141...lld:pubmed
pubmed-article:16219141pubmed:meshHeadingpubmed-meshheading:16219141...lld:pubmed
pubmed-article:16219141pubmed:meshHeadingpubmed-meshheading:16219141...lld:pubmed
pubmed-article:16219141pubmed:meshHeadingpubmed-meshheading:16219141...lld:pubmed
pubmed-article:16219141pubmed:meshHeadingpubmed-meshheading:16219141...lld:pubmed
pubmed-article:16219141pubmed:meshHeadingpubmed-meshheading:16219141...lld:pubmed
pubmed-article:16219141pubmed:meshHeadingpubmed-meshheading:16219141...lld:pubmed
pubmed-article:16219141pubmed:meshHeadingpubmed-meshheading:16219141...lld:pubmed
pubmed-article:16219141pubmed:meshHeadingpubmed-meshheading:16219141...lld:pubmed
pubmed-article:16219141pubmed:meshHeadingpubmed-meshheading:16219141...lld:pubmed
pubmed-article:16219141pubmed:meshHeadingpubmed-meshheading:16219141...lld:pubmed
pubmed-article:16219141pubmed:meshHeadingpubmed-meshheading:16219141...lld:pubmed
pubmed-article:16219141pubmed:meshHeadingpubmed-meshheading:16219141...lld:pubmed
pubmed-article:16219141pubmed:meshHeadingpubmed-meshheading:16219141...lld:pubmed
pubmed-article:16219141pubmed:meshHeadingpubmed-meshheading:16219141...lld:pubmed
pubmed-article:16219141pubmed:year2005lld:pubmed
pubmed-article:16219141pubmed:articleTitle[Impact of dose boost in skull base on recurrence of stage T4 nasopharyngeal carcinoma].lld:pubmed
pubmed-article:16219141pubmed:affiliationKey Laboratory of Oncology in Southern China, Guangzhou, Guangdong, P. R. China.lld:pubmed
pubmed-article:16219141pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16219141pubmed:publicationTypeEnglish Abstractlld:pubmed